Lindsay Grant, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 151 Bridge St, Pelham, NH 03076 Phone: 603-635-9153 |
Mr. Robert Matthew O'connell, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Applewood Rd, Pelham, NH 03076 Phone: 603-635-8619 Fax: 603-635-9095 |
Dr. Maithao Nguyen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 Atwood Rd, Pelham, NH 03076 Phone: 603-635-7996 |
Dr. Christian Erik Peterson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 151 Bridge St, Pelham, NH 03076 Phone: 603-635-9153 Fax: 603-635-8769 |
Mrs. Nancy Marie Veillette, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 151 Bridge St, Pelham, NH 03076 Phone: 603-635-9153 |
Tatiana Obukhov Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 Atwood Rd, Pelham, NH 03076 Phone: 603-635-7996 |
News Archive
The U.S. Department of Health and Human Services today announced the release of more than $1.84 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications.
Scientists have discovered a potential biomarker that could more accurately identify which patients with non-hypermutated cancers will respond to specialized immunotherapy drugs called immune checkpoint inhibitors, according to findings published in Science Translational Medicine.
Rare Disease Therapeutics, Inc. (RDT), the producer of orphan pharmaceuticals for the treatment of rare diseases, announced today that they have received FDA approval for PURIXAN™ (mercaptopurine) 20 mg/mL oral suspension--a new, easier-to-dose, liquid form of an established treatment for patients with Acute Lymphoblastic Leukemia (ALL).
Twenty-three non-commissioned officers from the Army, Navy, Air Force and Marine Corps have been given the opportunity to follow their dreams of becoming physicians thanks to the Uniformed Services University of the Health Sciences' (USU) Enlisted to Medical Degree Preparatory Program, or EMDP2.
Leading research at Newcastle University has been used to shape how dentistry can be carried out safely during the Covid-19 pandemic by mitigating the risks of dental aerosols.
› Verified 6 days ago